Effects of releasing recombinant human growth and differentiation factor-5 from poly(lactic- co -glycolic acid) microspheres for repair of the rat degenerated intervertebral disc

Abstract

Purpose:

The objective of this study was to investigate the therapeutic potential of poly(lactic-co-glycolic acid) (PLGA) microspheres loaded with recombinant human growth and differentiation factor-5 (rhGDF-5) on the disc degeneration induced by needle puncture in a rat caudal disc model.

Methods:

The rhGDF-5-loaded PLGA microspheres were prepared by the water-oil-water double-emulsion solvent evaporation method, and release kinetics was determined over 42 days. Rats that underwent 21-G needle puncture at rat tail discs were injected with rhGDF-5/PLGA microspheres at four weeks after needle injury. At eight weeks after the injection, disc height, glycosaminoglycans content, and DNA content of the discs were evaluated. In addition, gene expression analysis of aggrecan, collagen type I, and collagen type II in the rat nucleus pulposus was measured by real-time polymerase chain reaction. Rat discs were also assessed by histology using hematoxylin and eosin stain.

Results:

Encapsulation of rhGDF-5 in PLGA microspheres guaranteed a sustained release of active rhGDF-5 for more than 42 days. The injection of GDF-5/PLGA microspheres resulted in a statistically significant restoration of disc height (p < 0.01), improvement of sulfated glycosaminoglycan (p < 0.05), DNA content (p < 0.05), and significantly increased mRNA levels of collagen type II (p < 0.01), and the differentiation index (the ratio of collagen type II to collagen type I, p < 0.01). In addition, rhGDF-5/PLGA microspheres treatment also improved histological changes induced by needle puncture.

Conclusions:

The results of this study suggest that injection of rhGDF-5 loaded in PLGA microspheres into rat tail discs may be as a promising therapy strategy to regenerate or repair the degenerative disc.

Keywords

intervertebral disc degeneration human growth and differentiation factor-5 nucleus pulposus annulus fibrosus

Get full access to this article

View all access options for this article.

References

Rasmussen

Krum-Moller

Lauridsen

. Epidural steroid following discectomy for herniated lumbar disc reduces neurological impairment and enhances recovery: a randomized study with two-year follow-up. Spine 2008; 33: 2028–2033.

Buttermann

. The effect of spinal steroid injections for degenerative disc disease. Spine J 2004; 4: 495–505.

Olah

Molnar

Dobai

. The effects of weight bath traction hydrotherapy as a component of complex physical therapy in disorders of the cervical and lumbar spine: a controlled pilot study with follow-up. Rheumatol Int 2008; 28: 749–756.

Masuda

. Prevention of disc degeneration with growth factors. Eur Spine J 2006; 15: S422–S432.

Masuda

. Biological repair of the degenerated intervertebral disc by the injection of growth factors. Eur Spine J 2008; 17: 441–451.

Leo

Beck

. Collagen and proteoglycan abnormalities in the GDF-5-deficient mice and molecular changes when treating disk cells with recombinant growth factor. Spine 2004; 29: 2229–2234.

Yang

. Nucleus pulposus tissue engineering: a brief review. Eur Spine J 2009; 18: 1564–1572.

Chujo

Akeda

. Effects of growth differentiation factor-5 on the intervertebral disc – in vitro bovine study and in vivo rabbit disc degeneration model study. Spine 2006; 31: 2909–2917.

Walsh

Bradford

Lotz

. In vivo growth factor treatment of degenerated intervertebral discs. Spine 2004; 29: 156–163.

10.

Obata

Akeda

Imanishi

. Effect of autologous platelet-rich plasma-releasate on intervertebral disc degeneration in the rabbit anular puncture model: a preclinical study. Arthritis Res Ther 2012; 14: R241–R241.

11.

Pisal

Kosloski

Balu-Iyer

. Delivery of therapeutic proteins. Pharm Sci 2010; 99: 2557–2575.

12.

Yang

Chia

Chung

. Effect of preparation temperature on the characteristics and release profiles of PLGA microspheres containing protein fabricated by double-emulsion solvent extraction/evaporation method. J Control Release 2000; 69: 81–96.

13.

Shi

Wang

Varshney

. Microsphere-based drug releasing scaffolds for inducing osteogenesis of human mesenchymal stem cells in vitro. Eur J of Pharm Sci 2010; 39: 59–67.

14.

McGinity

. Preparation of microspheres by the solvent evaporation technique. Adv Drug Deliv Rev 1997; 28: 25–42.

15.

Zhang

La Marca

Hollister

. Developing consistently reproducible intervertebral disc degeneration at rat caudal spine by using needle puncture. Laboratory investigation. J Neurosurg Spine 2009; 10: 522–530.

16.

Masuda

Aota

Muehleman

. A novel rabbit model of mild, reproducible disc degeneration by an anulus needle puncture: correlation between the degree of disc injury and radiological and histological appearances of disc degeneration. Spine 2005; 30: 5–14.

17.

Masuda

Imai

Okuma

. Osteogenic protein-1 injection into a degenerated disc induces the restoration of disc height and structural changes in the rabbit anular puncture model. Spine (Phila Pa 1976) 2006; 1: 742–754.

18.

Farndale

Buttle

Barrett

. Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethyl-methylene blue. Biochim Biophys Acta 1986; 883: 173–177.

19.

Kim

Sah

Doong

. Fluorometric assay of DNA in cartilage explants using Hoechst 33258. Anal Biochem 1988; 174: 168–176.

20.

Huang KY, Yan JJ, Hsieh CC, et al. The in vivo biological effects of intradiscal recombinant human bone morphogenetic protein-2 on the injured intervertebral disc: An animal experiment. Spine 2007; 32:1174–1180.

21.

Moioli

Hong

Guardado

. Sustained release of TGF beta 3 from PLGA microspheres and its effect on early osteogenic differentiation of human mesenchymal stem cells. Tissue Eng 2006; 12: 537–546.

22.

Lam

Duenas

Daugherty

. Sustained release of recombinant human insulin-like growth factor-I for treatment of diabetes. J Control Release 2000; 67: 281–292.

23.

Shen

Pei

Duan

. Preparation and in vitro activity of controlled release microspheres incorporating bFGF. Chin J Traumatol 2008; 11: 22–27.

24.

Cohen

Yoshioka

Lucarelli

. Controlled delivery systems for proteins based on poly (lactic/glycolic acid) microspheres. Pharm Res 1991; 8: 713–720.

25.

Whittlesey

Shea

. Delivery systems for small molecule drugs, proteins, and DNA: the neuroscience/biomaterial interface. Exp Neurol 2004; 190: 1–16.

26.

Wang

Song

. Sustained release of insulin-like growth factor-1 from poly(lac-tide-co-glycolide) microspheres improves osseointegration of dental implants in type 2 diabetic rats. Eur J Pharmacol 2010; 640: 226–232.

27.

Karal-Yilmaz

Ozkan

Akgun

. Controlled release of imatinib mesylate from PLGA microspheres inhibit craniopharyngioma mediated angiogenesis. J Mater Sci Mater Med 2013; 24: 147–153.

28.

Razaq

Wilkins

Urban

JPG

. The effect of extracellular pH on matrix turnover by cells of the bovine nucleus pulposus. Eur Spine J 2003; 12: 341–349.

29.

Gorth

Mauck

Chiaro

. IL-1ra delivered from poly (lactic-co-glycolic acid) microspheres attenuates IL-1β-mediated degradation of nucleus pulposus in vitro. Arthritis Res Ther 2012; 14: R179–R179.